Advertisement

Topics

Chan Soon-Shiong Institute of Molecular Medicine Company Profile

21:29 EDT 23rd June 2018 | BioPortfolio

Chan Soon-Shiong Institute of Molecular Medicine (CSSIOMM) is a division of the Chan Soon-Shiong NantHealth Foundation, a 501(c)(3) non-profit medical research organization focused on transforming medical practice by facilitating digital molecular diagnosis. CSSIOMM is building a coalition dedicated to collaborating with health care, academic, government, and private sector partners to enable evidence based and molecularly driven, clinical decisions. The mission of CSSIOMM is to facilitate transformation of health systems to focus on health not just healthcare, to create a culture of caring and to support the development of next generation clinical scientists. The goal of the CSSIOMM is to improve the lives of the people and to enable sustainable health systems for the future.


News Articles [2171 Associated News Articles listed on BioPortfolio]

Chan Soon-Shiong Institute of Molecular Medicine at Windber Announces Milestone Publication of Nation’s First Standardized Genomic-Clinical Database, Correlating TCGA Molecular Signatures with Clinical End Points of 11,000 Patients across 33 Cancer Type

This TCGA - Pan Cancer Clinical Data Resource (TCGA-CDR), Published in Cell, Enables Investigators Access to Clinical Outcomes Correlated with Molecular Profiles at an Unprecedent...

SNMMI collaborates with industry to advance nuclear medicine and molecular imaging

(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Value Initiative Industry Alliance brings members of the corporate community to the ta...

Mount Sinai partners with Chan Zuckerberg Initiative to bring big data solution to biology

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Uri Laserson, PhD, Assistant Professor in the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai, a...

From curing cancer to saving troubled LA Times, biotech billionaire Soon-Shiong has grand plans

Whether it’s attempting to cure cancer or buying a troubled newspaper like the LA Times, Dr. Patrick Soon-Shiong has a penchant for the spotlight.

Biotech's Soon-Shiong hiring bankers for Nant cancer drug IPO

LOS ANGELES (Reuters) - Billionaire Patrick Soon-Shiong plans to take an experimental cancer treatment company public this year and has begun hiring bankers, the biotechnology entrepreneur told Reuter...

Billionaire Biotech Entrepreneur Patrick Soon-Shiong To Take New Cancer Company Public

Billionaire biotech entrepreneur Patrick Soon-Shiong has his eyes set on taking his newly formed oncology-focused Nant public this year.

Bridge between epigenetics and cancer treatment

(Goethe University Frankfurt) Professor Stefan Knapp from the Institute of Pharmaceutical Chemistry and Buchmann Institute of Molecular Life Sciences at the Goethe University has been elected as one ...

The Salk Institute and Indivumed partner to advance global cancer research

(Salk Institute) Salk and Indivumed have established a strategic partnership to advance research in precision oncology and personalized medicine by utilizing the highest quality molecular and clinical...

PubMed Articles [2489 Associated PubMed Articles listed on BioPortfolio]

Medicine and literature.

US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer.

Since 2007, the US National Cancer Institute (NCI) Office of Cancer Complementary and Alternative Medicine (OCCAM), together with the Cancer Institute of the China Academy of Chinese Medical Sciences ...

Laudation at the presentation of the Salomon Neumann Medal 2017 to Prof. Dr. med. med. Bernt-Peter Robra, MPH.

The German Society for Social Medicine and Prevention (DGSMP) confers the Salomon Neumann Medal for outstanding merit in the field of Preventive and Social Medicine. The Salomon Neumann Medal 2017 was...

Impact of quality of research on patient outcomes in the Institute of Medicine 2013 report on dietary sodium.

The 2013 Institute of Medicine report entitled "Sodium Intake in Populations: Assessment of Evidence" found inconsistent evidence of health benefit with dietary sodium intake

Unrecognized Cardiovascular Emergencies Among Medicare Patients.

The Institute of Medicine described diagnostic error as the next frontier in patient safety and highlighted a critical need for better measurement tools.

Clinical Trials [3052 Associated Clinical Trials listed on BioPortfolio]

The Jules Bordet Institute Molecular Profiling Program Feasibility Trial

Prior to the use of genomic tests for patient inclusion in clinical trials, it is essential for the Jules Bordet Institute (JBI) to pilot the logistical and technical aspects by examining ...

Molecular Tumor Board at the Center for Personalized Medicine Tübingen

Molecular Tumor Board at the Center for Personalized Medicine

Rady Children's Institute Genomic Biorepository

Rady Children's Institute for Genomic Medicine (RCI) will collect biological samples (such as blood), derived genomic sequences (from DNA and RNA), and clinical features in a Biorepository...

Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in Thailand

Total 7 institutions will be recruited i.e. Clinical Infectious Disease Research Unit Department of Clinical Tropical Medicine, Faculty of Tropical Medicine Mahidol University,Bamrasnara...

Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services

The purpose of this research is to gain insight into the way in which physicians adopt new practice techniques. In particular, we are interested in how medical innovations diffuse througho...

Companies [2977 Associated Companies listed on BioPortfolio]

Chan Soon-Shiong Institute of Molecular Medicine

Chan Soon-Shiong Institute of Molecular Medicine (CSSIOMM) is a division of the Chan Soon-Shiong NantHealth Foundation, a 501(c)(3) non-profit medical research organization focuse...

Chan Soon-Shiong Institute for Molecular Medicine

Chan Soon-Shiong Institute of Molecular Medicine (CSSIOMM) is a division of Chan Soon-Shiong NantHealth Foundation, a 501(c)(3) non-profit medical research organization focused on...

Chan Soon-Shiong Institute for Medicine

Chan Soon-Shiong Institute for Advanced Health

Chan Soon-Shiong Institute of Molecular Medicine at Windber

CSS Institute is a private, non-profit biomedical research institute established in 2000, as the Windber Research Institute, with a mission to improve patients’ care through ...

More Information about "Chan Soon-Shiong Institute of Molecular Medicine" on BioPortfolio

We have published hundreds of Chan Soon-Shiong Institute of Molecular Medicine news stories on BioPortfolio along with dozens of Chan Soon-Shiong Institute of Molecular Medicine Clinical Trials and PubMed Articles about Chan Soon-Shiong Institute of Molecular Medicine for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chan Soon-Shiong Institute of Molecular Medicine Companies in our database. You can also find out about relevant Chan Soon-Shiong Institute of Molecular Medicine Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record